Citigroup’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-220,000
Closed -$1.53M 5956
2025
Q4
$1.53M Hold
220,000
﹤0.01% 2831
2025
Q3
$1.42M Hold
220,000
﹤0.01% 2939
2025
Q2
$1.46M Hold
220,000
﹤0.01% 2921
2025
Q1
$1.43M Hold
220,000
﹤0.01% 2998
2024
Q4
$1.78M Buy
220,000
+120,000
+120% +$989K ﹤0.01% 2911
2024
Q3
$817K Hold
100,000
﹤0.01% 3418
2024
Q2
$697K Buy
+100,000
New +$757K ﹤0.01% 3168
2023
Q1
Sell
-75,100
Closed -$471K 5508
2022
Q4
$471K Sell
75,100
-930,500
-93% -$6.5M ﹤0.01% 3217
2022
Q3
$6.98M Buy
1,005,600
+430,500
+75% +$2.99M 0.01% 1353
2022
Q2
$4.8M Buy
+575,100
New +$8.04M ﹤0.01% 1565
2022
Q1
Sell
-895,000
Closed -$24.8M 6304
2021
Q4
$24.8M Buy
895,000
+695,000
+348% +$18.6M 0.01% 889
2021
Q3
$5.58M Buy
+200,000
New +$5.67M ﹤0.01% 1746
2021
Q1
Sell
-220,200
Closed -$4.57M 6290
2020
Q4
$4.57M Sell
220,200
-49,500
-18% -$923K ﹤0.01% 2149
2020
Q3
$4.18M Buy
269,700
+38,900
+17% +$670K ﹤0.01% 2021
2020
Q2
$4.21M Sell
230,800
-300
-0.1% -$5.29K ﹤0.01% 2027
2020
Q1
$3.54M Sell
231,100
-243,400
-51% -$5.87M ﹤0.01% 1958
2019
Q4
$14.2M Buy
474,500
+96,800
+26% +$2.52M 0.01% 1199
2019
Q3
$8.24M Buy
377,700
+39,000
+12% +$892K 0.01% 1538
2019
Q2
$8.56M Sell
338,700
-150,200
-31% -$3.57M 0.01% 1510
2019
Q1
$12.1M Sell
488,900
-38,100
-7% -$910K 0.01% 1149
2018
Q4
$9.74M Sell
527,000
-69,200
-12% -$1.65M 0.01% 1272
2018
Q3
$15.3M Sell
596,200
-34,500
-5% -$790K 0.01% 1012
2018
Q2
$14.7M Sell
630,700
-224,900
-26% -$4.65M 0.01% 994
2018
Q1
$13.6M Sell
855,600
-7,400
-0.9% -$138K 0.01% 1030
2017
Q4
$18M Buy
863,000
+270,200
+46% +$4.28M 0.01% 897
2017
Q3
$8.48M Sell
592,800
-37,600
-6% -$569K 0.01% 1344
2017
Q2
$10.9M Sell
630,400
-970,200
-61% -$11.6M 0.01% 1088
2017
Q1
$17.6M Buy
1,600,600
+1,259,700
+370% +$17.3M 0.02% 804
2016
Q4
$4.95M Sell
340,900
-20,000
-6% -$367K ﹤0.01% 1850
2016
Q3
$8.84M Buy
360,900
+30,400
+9% +$787K 0.01% 1176
2016
Q2
$6.63M Buy
330,500
+101,800
+45% +$2.88M 0.01% 1325
2016
Q1
$6.02M Sell
228,700
-1,300
-0.6% -$96.1K 0.01% 1394
2015
Q4
$23.3M Buy
230,000
+78,200
+52% +$8.79M 0.02% 677
2015
Q3
$27M Buy
151,800
+111,200
+274% +$25.9M 0.03% 581
2015
Q2
$9.01M Buy
40,600
+13,000
+47% +$2.88M 0.01% 1284
2015
Q1
$5.45M Sell
27,600
-6,800
-20% -$1.21M 0.01% 1657
2014
Q4
$4.93M Buy
+34,400
New +$4.63M ﹤0.01% 1806
2014
Q2
Sell
-7,100
Closed -$936K 7111
2014
Q1
$936K Buy
+7,100
New +$971K ﹤0.01% 2927
2013
Q4
Sell
-20,000
Closed -$2.09M 6977
2013
Q3
$2.09M Hold
20,000
﹤0.01% 2423
2013
Q2
$1.72M Buy
+20,000
New +$1.58M ﹤0.01% 2478

Other funds holding BHC

Citigroup's BHC Position: Q1 2026 in Review

Citigroup increased its Bausch Health (BHC) stake by 2.4% in Q1 2026, buying an estimated $30K and bringing the position to 210,877 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Citigroup first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q3 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Citigroup held 210,877 shares of Bausch Health worth $1.14M as of Q1 2026.
  • Citigroup bought 5,014 Bausch Health shares in Q1 2026, an estimated $30K.
  • Bausch Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3036 holding.
  • Citigroup first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Bausch Health position peaked at $17.9M in Q3 2015.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.